CVS Health EBITDA Margin 2010-2023 | CVS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CVS Health (CVS) over the last 10 years. The current EBITDA margin for CVS Health as of December 31, 2023 is .
| CVS Health EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$357.78B |
$18.11B |
5.06% |
| 2023-09-30 |
$347.81B |
$18.30B |
5.26% |
| 2023-06-30 |
$339.20B |
$10.62B |
3.13% |
| 2023-03-31 |
$330.92B |
$12.03B |
3.64% |
| 2022-12-31 |
$322.47B |
$12.18B |
3.78% |
| 2022-09-30 |
$315.23B |
$10.91B |
3.46% |
| 2022-06-30 |
$307.86B |
$18.41B |
5.98% |
| 2022-03-31 |
$299.84B |
$18.12B |
6.04% |
| 2021-12-31 |
$292.11B |
$18.23B |
6.24% |
| 2021-09-30 |
$285.06B |
$18.46B |
6.47% |
| 2021-06-30 |
$278.32B |
$18.19B |
6.54% |
| 2021-03-31 |
$271.05B |
$18.51B |
6.83% |
| 2020-12-31 |
$268.71B |
$18.35B |
6.83% |
| 2020-09-30 |
$266.04B |
$18.82B |
7.07% |
| 2020-06-30 |
$263.80B |
$18.48B |
7.01% |
| 2020-03-31 |
$261.89B |
$17.10B |
6.53% |
| 2019-12-31 |
$256.78B |
$16.36B |
6.37% |
| 2019-09-30 |
$244.31B |
$16.08B |
6.58% |
| 2019-06-30 |
$226.99B |
$15.26B |
6.72% |
| 2019-03-31 |
$210.48B |
$14.05B |
6.67% |
| 2018-12-31 |
$194.58B |
$12.89B |
6.62% |
| 2018-09-30 |
$188.56B |
$12.83B |
6.80% |
| 2018-06-30 |
$187.25B |
$12.75B |
6.81% |
| 2018-03-31 |
$186.02B |
$12.43B |
6.68% |
| 2017-12-31 |
$184.79B |
$12.20B |
6.60% |
| 2017-09-30 |
$182.37B |
$12.05B |
6.61% |
| 2017-06-30 |
$180.81B |
$12.37B |
6.84% |
| 2017-03-31 |
$178.85B |
$12.47B |
6.97% |
| 2016-12-31 |
$177.55B |
$12.86B |
7.24% |
| 2016-09-30 |
$172.70B |
$12.55B |
7.26% |
| 2016-06-30 |
$166.73B |
$11.97B |
7.18% |
| 2016-03-31 |
$160.17B |
$11.75B |
7.33% |
| 2015-12-31 |
$153.29B |
$11.57B |
7.55% |
| 2015-09-30 |
$149.20B |
$11.05B |
7.40% |
| 2015-06-30 |
$145.58B |
$10.91B |
7.49% |
| 2015-03-31 |
$143.01B |
$10.85B |
7.59% |
| 2014-12-31 |
$139.37B |
$10.73B |
7.70% |
| 2014-09-30 |
$135.14B |
$10.60B |
7.84% |
| 2014-06-30 |
$132.05B |
$10.49B |
7.94% |
| 2014-03-31 |
$128.70B |
$10.21B |
7.93% |
| 2013-12-31 |
$126.76B |
$9.91B |
7.82% |
| 2013-09-30 |
$125.31B |
$9.97B |
7.96% |
| 2013-06-30 |
$123.61B |
$9.61B |
7.78% |
| 2013-03-31 |
$123.07B |
$9.33B |
7.58% |
| 2012-12-31 |
$123.12B |
$8.96B |
7.28% |
| 2012-09-30 |
$120.04B |
$8.58B |
7.15% |
| 2012-06-30 |
$116.48B |
$8.31B |
7.13% |
| 2012-03-31 |
$112.18B |
$8.05B |
7.17% |
| 2011-12-31 |
$107.08B |
$7.90B |
7.38% |
| 2011-09-30 |
$103.08B |
$7.67B |
7.44% |
| 2011-06-30 |
$100.12B |
$7.52B |
7.51% |
| 2011-03-31 |
$97.71B |
$7.52B |
7.69% |
| 2010-12-31 |
$95.78B |
$7.61B |
7.94% |
| 2010-09-30 |
$96.79B |
$7.72B |
7.98% |
| 2010-06-30 |
$97.72B |
$7.74B |
7.92% |
| 2010-03-31 |
$98.58B |
$7.85B |
7.96% |
| 2009-12-31 |
$98.22B |
$7.81B |
7.96% |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$85.423B |
$357.776B |
|
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|
